A little stress is good:: IFN-γ, demyelination, and multiple sclerosis

被引:46
|
作者
Lees, Jason R.
Cross, Anne H.
机构
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2007年 / 117卷 / 02期
关键词
D O I
10.1172/JCI31254
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The exact role(s) of the cytokine IFN-gamma in the demyelinating disease multiple sclerosis remain controversial, with evidence suggesting both detrimental and protective effects of the cytokine in MS and MS models such as EAE. The study by Lin and coworkers in this issue of the JCI produces evidence that protective effects of IFN-gamma on mature oligodendrocytes during EAE induction are mediated via activation of the pancreatic ER kinase (PERK), resulting in induction of the endoplasmic reticular stress response pathway (see the related article beginning on page 448). Modulation of this stress pathway has what we believe to be novel therapeutic potential for MS.
引用
收藏
页码:297 / 299
页数:3
相关论文
共 50 条
  • [41] The Fulcrum of Demyelination in Multiple Sclerosis
    Ganesan, Abinaya
    Muralidharan, Pooja
    Ramya, Lakshmi Narasimhan
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2023, 24 (07) : 579 - 588
  • [42] NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis
    Malhotra, Sunny
    Rio, Jordi
    Urcelay, Elena
    Nurtdinov, Ramil
    Bustamante, Marta F.
    Fernandez, Oscar
    Oliver, Begona
    Zettl, Uwe
    Brassat, David
    Killestein, Joep
    Lechner-Scott, Jeannette
    Drulovic, Jelena
    Chan, Andrew
    Martinelli-Boneschi, Filippo
    Garcia-Merino, Antonio
    Montalban, Xavier
    Comabella, Manuel
    BRAIN, 2015, 138 : 644 - 652
  • [43] Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosis
    Orpez-Zafra, Teresa
    Pavia, Jose
    Pinto-Medel, Maria J.
    Hurtado-Guerrero, Isaac
    Rodriguez-Bada, Jose L.
    Montanez, Elisa Martin
    Fernandez, Oscar
    Leyva, Laura
    Oliver-Martos, Begona
    BIOANALYSIS, 2015, 7 (22) : 2869 - 2880
  • [44] The role of cell type-specific responses in IFN-β therapy of multiple sclerosis
    Zula, Joana A.
    Green, Holly C.
    Ransohoff, Richard M.
    Rudick, Richard A.
    Stark, George R.
    van Boxel-Dezaire, Anette H. H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (49) : 19689 - 19694
  • [45] Pharmacogenetics of autoimmune diseases:: Research issues in the case of Multiple Sclerosis and the role of IFN-β
    Macciardi, F
    Boneschi, FM
    Cohen, D
    JOURNAL OF AUTOIMMUNITY, 2005, 25 : 1 - 5
  • [46] IFN-γ and TNF-α Gene Polymorphisms in Multiple Sclerosis Patients in Northwest Iran
    Asgharzadeh, Mohammad
    Najafi-Ghalehlou, Nima
    Poor, Behroz M.
    Asgharzadeh, Vahid
    Pourostadi, Mahya
    Vegari, Ali
    Kafil, Hossein S.
    Fadaee, Manouchehr
    Farhoudi, Mehdi
    Rashedi, Jalil
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (03) : 520 - 525
  • [47] An older dog with newer tricks Predicting efficacy of IFN-β treatment for multiple sclerosis
    Wu, Gregory F.
    Longbrake, Erin E.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (02):
  • [48] Identification of Monotonically Differentially Expressed Genes for IFN-β-Treated Multiple Sclerosis Patients
    Tian, Suyan
    Zhang, Lei
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [49] IFN-β-driven long-term gene signatures as biomarkers in multiple sclerosis
    Croze, E.
    Yamaguchi, K. D.
    Knappertz, V
    Reder, A. T.
    Salamon, H.
    PHARMACOGENOMICS, 2012, 13 (16) : 1884 - 1885